What is the recommended dosing regimen of mexiletine in adults?

Mexiletine Dosing in Adults

For neuropathic pain, mexiletine should be dosed at 225-675 mg/day, with a medium dose of 450 mg/day appearing most appropriate, while for ventricular arrhythmias, initiate at 200 mg every 8 hours with food or antacid, titrating by 50-100 mg increments every 2-3 days to a usual maintenance dose of 200-300 mg every 8 hours (maximum 1200 mg/day). 1

Standard Dosing for Ventricular Arrhythmias

Initial Therapy:

• Start with 200 mg every 8 hours when rapid control is not essential 1
• Administer with food or antacid to minimize gastrointestinal side effects 1
• Allow minimum of 2-3 days between dose adjustments 1

Dose Titration:

• Adjust in 50-100 mg increments up or down based on response and tolerance 1
• Most patients achieve satisfactory control at 200-300 mg every 8 hours 1, 2
• If inadequate response at 300 mg every 8 hours and patient tolerates well, may increase to 400 mg every 8 hours 1
• Maximum daily dose: 1200 mg/day (do not exceed due to increased CNS side effects) 1

Loading Dose (when rapid control essential):

• 400 mg initial loading dose, followed by 200 mg in 8 hours 1
• Onset of therapeutic effect occurs within 30 minutes to 2 hours 1

Alternative Dosing Schedule

Every 12-Hour Regimen:

• Patients responding to ≤300 mg every 8 hours may be transferred to same total daily dose divided every 12 hours 1
• Maximum of 450 mg every 12 hours to achieve desired response 1
• This schedule improves convenience and compliance while maintaining efficacy 1, 3
• Hour-by-hour analysis shows consistent PVC suppression throughout 12-hour intervals 3

Neuropathic Pain Dosing

For painful diabetic neuropathy and other neuropathic pain conditions:

• Use doses of 225-675 mg/day 4
• Medium dose of 450 mg/day appears most appropriate - efficacy does not rise proportionally with higher antiarrhythmic doses 5
• Mexiletine is prescribed as second- or third-line treatment for neuropathic pain due to poor side effect profile 4
• Reserve for patients refractory to other treatments 4

Special Population Adjustments

Renal Failure:

• Patients with renal failure generally require usual doses 1

Severe Liver Disease:

• Require lower doses and must be monitored closely 1

Severe Right-Sided Congestive Heart Failure:

• Can reduce hepatic metabolism; may require reduced doses 1

Monitoring Requirements

• Clinical and electrocardiographic evaluation (including Holter monitoring if necessary) needed to determine antiarrhythmic effect and guide titration 1
• Long-term studies show 69-80% of patients maintain ≥70% VPC suppression at 3-month intervals 6
• Most frequently used maintenance dosage is 600 mg/day (50-56% of patients) 6

Common Pitfalls and Caveats

Side Effects:

• Gastrointestinal and CNS side effects are most common 2, 7
• At medium dose range (450 mg/day) for neuropathic pain, side effects are negligible, even less than placebo 5
• Side effects warrant discontinuation in approximately 8-20% of patients 2, 6

Drug Interactions:

• Plasma levels may be affected by concomitant drugs 1
• When transferring from lidocaine, stop infusion when first oral mexiletine dose given; consider additive adverse effects 1

Cardiac Considerations:

• Minimal effects on hemodynamic variables or cardiac function 7
• Low proarrhythmic potential compared to other antiarrhythmics 7
• Cardiac assessment required as mexiletine may have pro-arrhythmic effects 8
• Patients should be monitored as any patient with cardiac problems prescribed a class 1b anti-arrhythmic 8

Clinical Context:

• For neuropathic pain, patients with stabbing/burning pain, heat sensations, or formication benefit most 5
• In therapy-refractory ventricular tachyarrhythmias and electrical storms, adjunctive mexiletine may stabilize patients 9, 10, 11